ArticleBioinformatics (Oxford, England)2025
miRBench: novel benchmark datasets for microRNA binding site prediction that mitigate against prevalent microRNA frequency class bias.
Article in Bioinformatics (Oxford, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- miRBind2 enables sequence-only prediction of miRNA binding and transcript repression.Bioinformatics (Oxford, England) · 2026Article
- DeepExoMir: A Reproducible RNA Language Model Framework for CLIP-Seq-Supported MicroRNA Target-Site Prioritization.International journal of molecular sciences · 2026Article
- MiRformer: a dual-transformer-encoder framework for predicting microRNA-mRNA interactions from paired sequences.Bioinformatics (Oxford, England) · 2026Article
- Agentomics: an agentic system that autonomously develops novel state-of-the-art solutions for biomedical machine learning tasks.Bioinformatics (Oxford, England) · 2026Article
- MicroRNA target gene prediction model based on input-feature dependency and sample data expansion technique.PLoS computational biology · 2026Article
- Generalizable deep-learning-based mRNA-protein interaction prediction strongly depends on protein diversity.Journal of cheminformatics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
motivationMicroRNAs (miRNAs) are crucial regulators of gene expression, but the precise mechanisms governing their binding to target sites remain unclear. A major contributing factor to this is the lack of unbiased experimental datasets for training accurate prediction models. While recent experimental advances have provided numerous miRNA-target interactions, these are solely positive interactions. Generating negative examples in silico is challenging and prone to introducing biases, such as the miRNA frequency class bias identified in this work. Biases within datasets can compromise model generalization, leading models to learn dataset-specific artifacts rather than true biological patterns.
resultsWe introduce a novel methodology for negative sample generation that effectively mitigates the miRNA frequency class bias. Using this methodology, we curate several new, extensive datasets and benchmark several state-of-the-art methods on them. We find that a simple convolutional neural network model, retrained on some of these datasets, is able to outperform state-of-the-art methods reaching average precision scores between 0.81 and 0.86 in test datasets. This highlights the potential for leveraging unbiased datasets to achieve improved performance in miRNA binding site prediction. To facilitate further research and lower the barrier to entry for machine learning researchers, we provide an easily accessible Python package, miRBench, for dataset retrieval, sequence encoding, and the execution of state-of-the-art models. AVAILABILITY AND IMPLEMENTATION: The miRBench Python package is accessible at https://github.com/katarinagresova/miRBench/releases/tag/v1.0.1.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.